Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Organon and Co | OGN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 18.42 | 04:01:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 18.42 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 10.835 - 24.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 18.42 | USD |
Organon (OGN) Options Flow Summary
Organon and Co Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.71B | 255.64M | - | 6.26B | 1.02B | 4.00 | 4.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Organon News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.88 | 18.75 | 17.38 | 18.22 | 2,080,312 | 0.54 | 3.02% |
| 1 Month | 18.81 | 18.825 | 17.33 | 18.02 | 2,101,788 | -0.39 | -2.07% |
| 3 Months | 17.17 | 19.08 | 15.84 | 17.85 | 2,344,269 | 1.25 | 7.28% |
| 6 Months | 15.56 | 19.08 | 10.835 | 14.81 | 3,485,477 | 2.86 | 18.38% |
| 1 Year | 23.41 | 24.79 | 10.835 | 16.88 | 3,213,095 | -4.99 | -21.32% |
| 3 Years | 34.20 | 39.475 | 10.835 | 24.67 | 2,557,871 | -15.78 | -46.14% |
| 5 Years | 34.20 | 39.475 | 10.835 | 24.67 | 2,557,871 | -15.78 | -46.14% |
Organon Description
| Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. |
